Indian Stock Market: Prime Investment Opportunities for August 7, 2024
Shree Cement Ltd
Rs.25,827.90/-
Shree Cement Sees Profit Decline Amid Modest Revenue Growth
- Shree Cement reported a 51.31% decline in consolidated net profit, totaling Rs 278.45 crore for Q1 FY25, falling short of analyst expectations.
- Despite the profit drop, revenue from operations increased by 1.73% to Rs 5,123.96 crore, showing some resilience.
- Shree Cement has delivered a 10.64% return over the past year.
State Bank of India
Rs.801.20/-
State Bank of India Announces New Leadership
- Challa Sreenivasulu Setty appointed as Chairman of SBI for a three-year term starting August 28, 2024.
- Rana Ashutosh Kumar Singh will assume the role of Managing Director, succeeding Setty.
- Setty’s leadership is anticipated to enhance SBI’s strategic direction and operational efficiency.
- SBI has delivered a 42.92% return over the past year.
Tata Steel Ltd
Rs.152.60/-
Tata Steel Navigates Legal Challenges and Plans Expansion
- Tata Steel is exploring legal options regarding potential dues from a Supreme Court ruling that may apply retrospectively.
- The company has noted contingent liabilities of Rs 17,347 crore pending clarity on state levies in Odisha.
- Tata Steel plans to increase production capacity by 45% to 11 mtpa as part of its expansion strategy.
- Tata Steel has delivered a 26.06% return over the past year.
Hindalco Industries Ltd
Rs.622.80/-
Hindalco Faces CBI Corruption Charges
- Hindalco Industries has been charged by the CBI for alleged corruption involving environmental clearances for coal mining between 2011 and 2013.
- The investigation centers on claims of bribery to secure approvals for mining in a critically polluted area in Odisha.
- Hindalco has delivered a 32.15% return over the past year.
Tech Mahindra Ltd
Rs.1,502.90/-
Tech Mahindra Partners with Horizon3.ai for AI-Based Cybersecurity
- Tech Mahindra has partnered with Horizon3.ai to provide AI-based cybersecurity solutions.
- The collaboration aims to enhance threat detection and compliance capabilities for global customers.
- Tech Mahindra plans to unlock growth potential despite past struggles.
- Tech Mahindra has delivered a 23.04% return over the past year.
VIP Industries Ltd
Rs.452.05/-
VIP Industries Reports Significant Profit Decline Amid Operational Challenges
- VIP Industries reported a 93% drop in profit, falling to Rs 4.04 crore from Rs 57.8 crore.
- Despite the profit decline, revenue saw a slight increase of 0.4%, reaching Rs 638.9 crore.
- The company faces potential operational challenges due to political unrest in Bangladesh, impacting distribution and supply chains.
- VIP Industries has delivered an 11.44% return over the past three years.
Cummins India Ltd
Rs.3,644.90/-
Cummins India Reports Strong Q1FY25 Earnings
- Cummins India posted a 33% YoY increase in net profit, reaching Rs 419.8 crore for Q1FY25.
- Standalone revenue grew by 4%, totaling Rs 2,262 crore, driven by strong domestic demand.
- Nomura maintains a Neutral rating with a target price of Rs 3,470, indicating potential downside.
- Cummins India has delivered a 99.68% return over the past year.
PI Industries Ltd
Rs.4,418.90/-
PI Industries Reports Robust Q1FY25 Growth
- PI Industries posted a 17.2% increase in net profit, reaching Rs 448.8 crore for Q1 FY25, up from Rs 383 crore last year.
- Revenue grew by 8.3%, totaling Rs 2,068.9 crore compared to Rs 1,910 crore in the same quarter of the previous fiscal year.
- The company’s EBITDA surged by 24.7% to Rs 583.2 crore, indicating strong operational performance and improved margins.
- PI Industries has delivered an 11.44% return over the past year.
Infosys Ltd
Rs.1,781.90/-
Infosys Faces Significant GST Tax Demand Challenges
- Infosys is contending with a substantial tax demand of Rs 32,403 crore from the Indian government related to GST liabilities.
- The company has received partial relief, with Rs 3,898 crore withdrawn, but still faces a remaining demand of Rs 28,000 crore.
- Nasscom has criticized the tax demands, suggesting misunderstandings about the IT sector’s operational model.
- Infosys has delivered a 25.76% return over the past year.
Zydus Wellness Ltd
Rs.2,291.25/-
Stake Changes in Zydus Wellness Amid Strong Sales Growth
- True North’s Threpsi Care LLP sold a 2.67% stake in Zydus Wellness for Rs 374 crore.
- Quant Mutual Fund acquired the same percentage of shares at an average price of Rs 2,201.40 each.
- Zydus Wellness reported a robust 20% YoY increase in net sales and cleared its debt, enhancing financial stability.
- Zydus Wellness has delivered a 51.83% return over the past year.
Krsnaa Diagnostics Ltd
Rs.661.85/-
Krsnaa Diagnostics Reports Robust Growth Amid CEO Resignation
- Krsnaa Diagnostics posted a 22.4% increase in profit, reaching Rs 17.9 crore year-over-year.
- Revenue surged by 22%, totaling Rs 170.2 crore, reflecting strong business performance.
- CEO Prashant Pandurangrao Deshmukh resigned, marking a significant leadership change.
- Krsnaa Diagnostics has delivered 23.6% returns over the past year.
Lupin Ltd
Rs.1,999.00/-
Lupin Reports Impressive Q1 FY25 Growth
- Lupin’s net profit surged by 77.2% year-on-year, reaching Rs 801 crore for Q1 FY25.
- Revenue from operations increased by 16.3%, totaling Rs 5,600.3 crore, bolstered by new product launches and strong performance.
- The company has established Lupin Lanka as a wholly-owned subsidiary amidst facing a substantial GST recovery demand.
- Lupin has delivered 80.2% returns over the past year.
TVS Motor Company Ltd
Rs.2,561.00/-
TVS Motor Company Posts Impressive Q1 FY25 Earnings
- TVS Motor Company reported a 23% increase in net profit, reaching ₹577 crore for Q1 FY25, fueled by strong sales.
- Revenue from operations grew 16% year-on-year, totaling ₹8,376 crore, driven by high demand across two-wheeler segments.
- The company achieved its highest-ever operating EBITDA of ₹960 crore, with an improved margin of 11.5%, showcasing effective cost management.
- TVS Motor has delivered 337.47% returns over the past three years.
Gland Pharma Ltd
Rs.2,035.00/-
Gland Pharma’s Q1 FY25: Profit Decline Despite Revenue Growth
- Gland Pharma reported a 26% year-on-year decline in net profit, totaling ₹143.8 crore for Q1 FY25.
- Revenue rose by 16% to ₹1,401.7 crore, up from last year’s ₹1,208.7 crore.
- Sales and EBITDA significantly missed analyst estimates, prompting Nomura to downgrade the stock’s rating.
- Despite the profit decline, Gland Pharma has delivered 57.57% returns over the past year.
Also read: Sheikh Hasina, Nahid Islam, 45 Minutes and the Explosive Turmoil in Bangladesh
Top 15 Incredibly Beautiful Women from Across the World
Krystyna Pyszkova, Representing The Czech Republic, Crowned Miss World 2024!
Fashion Influencer Nancy Tyagi Makes History with Self-Stitched Outfit at Cannes Film Festival
Source: Google
Business Desk: News Lounge 24×7
Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of News Lounge 24×7. We advise investors to check with certified experts before taking any investment decisions.
Discover more from News Lounge 24x7
Subscribe to get the latest posts sent to your email.